https://www.benzinga.com/news/earnings/23/03/31170769/fibrogens-return-on-capital-employed-insights
FibroGen's Return On Capital Employed Insights - Benzinga
return on capital employedfibrogeninsightsbenzinga
https://www.globenewswire.com/fr/news-release/2017/10/18/1149112/33525/en/FibroGen-Announces-Acceptance-by-China-FDA-of-Roxadustat-New-Drug-Application-NDA-for-Treatment-of-Anemia-Associated-With-Dialysis-and-Non-Dialysis-Chronic-Kidney-Disease-CKD.html
FibroGen Announces Acceptance by China FDA of Roxadustat
Triggers Milestone Payment of $15 Million by AstraZeneca ...
china fdafibrogenannouncesacceptanceroxadustat
https://www.pissedconsumer.com/company/fibrogen/customer-service.html
FibroGen Customer Service Phone Number 1-877-934-3436, Email, Help Center
How to contact FibroGen customer support at toll-free phone number? Call or write an email to ir@fibrogen.com to resolve FibroGen issues. Visit the company...
customer servicephone number1 877
https://www.macrotrends.net/stocks/charts/FGEN/fibrogen/net-profit-margin
FibroGen Net Profit Margin 1970-1969 | FGEN | MacroTrends
FibroGen net profit margin from 1970 to 1969. Net profit margin can be defined as net Income as a portion of total sales revenue.
net profit marginfibrogen19701969fgen
https://www.barchart.com/stocks/quotes/FGEN/comparison?symbols=TAK%2CZTS%2CONC%2CUTHR%2CSMMT
FGEN Comparison for Fibrogen CS Stock - Barchart.com
Compare Fibrogen Inc CS (FGEN) to other companies with price, technicals, performance, and fundamentals comparison.
fgencomparisonfibrogencsstock
https://www.barchart.com/stocks/quotes/FGEN/comparison
FGEN Comparison for Fibrogen CS Stock - Barchart.com
Compare Fibrogen Inc CS (FGEN) to other companies with price, technicals, performance, and fundamentals comparison.
fgencomparisonfibrogencsstock
https://www.biospace.com/fibrogen-announces-results-for-matterhorn-a-phase-3-clinical-study-of-roxadustat-for-the-treatment-of-anemia-in-patients-with-myelodysplastic-syndromes-mds-study-did-not-meet-primary-endpoint
FibroGen Announces Results for MATTERHORN, a Phase 3 Clinical Study of Roxadustat for the Treatment...
May 5, 2023 - FibroGen, Inc. (NASDAQ: FGEN) today announced that MATTERHORN, a Phase 3 clinical study of roxadustat for treatment of anemia in patients with...
https://www.globenewswire.com/fr/news-release/2021/02/18/2177867/33525/en/FibroGen-to-Report-Fourth-Quarter-and-Full-Year-2020-Financial-Results.html
FibroGen to Report Fourth Quarter and Full Year 2020
SAN FRANCISCO, Feb. 18, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2020 financial results on...
fourth quarterfull yearfibrogenreport2020
https://www.globenewswire.com/fr/news-release/2021/10/26/2320479/33525/en/FibroGen-to-Report-Third-Quarter-2021-Financial-Results.html
FibroGen to Report Third Quarter 2021 Financial Results
SAN FRANCISCO, Oct. 26, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its third quarter 2021 financial results on Tuesday,...
third quarter2021 financialfibrogenreportresults
https://www.barchart.com/story/news/35002045/fibrogen-initiates-phase-2-monotherapy-trial-of-fg-3246-a-first-in-class-cd46-targeting-adc-in-metastatic-castration-resistant-prostate-cancer
FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in...
FG-3246 Phase 2 dose optimization trial to enroll 75 patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-androgen receptor...
https://www.fiercebiotech.com/research/hypoxia-boosts-fetal-hemoglobin-red-blood-cells
AZ, FibroGen's roxadustat holds promise for sickle cell disease
Oct 18, 2022 - The finding opens the door to the use of proline hydroxylase inhibitors to treat beta thalassemia and sickle cell disease.
sickle cellazfibrogenroxadustatholds
https://www.barchart.com/stocks/quotes/FGEN/overview
FGEN - Fibrogen CS Stock Price - Barchart.com
Fibrogen Inc CS stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
stock pricefgenfibrogencsbarchart
https://www.barchart.com/stocks/quotes/FGEN/earnings-estimates
FGEN Earnings Estimates for Fibrogen CS Stock - Barchart.com
Earnings estimates and surprises for Fibrogen Inc CS (FGEN) are an important tool used to evaluate the company's overall strength and value of the stock.
earnings estimatesfgenfibrogencsstock
https://www.barchart.com/etfs-funds/quotes/FGEN
FGEN - Fibrogen CS Stock Price - Barchart.com
Fibrogen Inc CS etfs funds price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.
stock pricefgenfibrogencsbarchart
https://www.barchart.com/stocks/quotes/FGEN/news
FGEN News for Fibrogen CS - Barchart.com
Latest news headlines for Fibrogen Inc CS with market analysis and analyst commentary.
fgennewsfibrogencsbarchart
https://www.barchart.com/stocks/quotes/FGEN/insider-trades
FGEN Insider Trades for Fibrogen CS Stock - Barchart.com
Insider trades for Fibrogen Inc CS (FGEN): buy, sell, award and other transactions for FGEN insiders.
insider tradesfgenfibrogencsstock
https://www.barchart.com/story/news/36417907/fibrogen-to-present-at-the-oppenheimer-movers-in-rare-disease-summit
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the...
rare diseasefibrogenpresent
https://www.barchart.com/story/news/36032327/fibrogen-reports-third-quarter-2025-financial-results-and-provides-business-update
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
Completed the sale of FibroGen China to AstraZeneca for approximately $220 million Initiated the Phase 2 monotherapy trial of FG-3246, a potential...
2025 financial resultsthird quarterfibrogenreports
https://www.barchart.com/story/news/34431916/fibrogen-to-present-at-the-h-c-wainwright-27th-annual-global-investment-conference
FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Company will be attending and presenting at the H.C....
https://www.barchart.com/stocks/quotes/FGEN/sec-filings
FGEN SEC Filings for Fibrogen CS Stock - Barchart.com
SEC Filings for Fibrogen Inc CS (FGEN) including Annual 10-K and Quarterly 10-Q Reports.
sec filingsfgenfibrogencsstock
https://robinhood.com/us/en/stocks/FGEN/
FibroGen: FGEN Stock Price Quote & News | Robinhood
You can watch FGEN and buy and sell other stocks, ETFs, and their options commission-free on Robinhood. Change the date range, see whether others are buying or...
stock pricefibrogenfgenquotenews
https://www.barchart.com/stocks/quotes/FGEN/technical-analysis
FGEN Technical Analysis for Fibrogen CS Stock - Barchart.com
Technical Analysis Summary for Fibrogen Inc CS with Moving Average, Stochastics, MACD, RSI, Average Volume.
technical analysisfgenfibrogencsstock
https://www.barchart.com/stocks/quotes/FGEN/historical-download
FGEN Historical Data for Fibrogen CS Stock - Barchart.com
Historical data and Price History back to Jan. 1, 1980 for Fibrogen Inc CS (FGEN) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for...
historical datafgenfibrogencsstock
https://www.barchart.com/stocks/quotes/FGEN/opinion
FGEN Barchart Opinion for Fibrogen CS Stock - Barchart.com
Trading Signals for Fibrogen Inc CS with Buy, Sell, Hold recommendations, technical analysis, and trading strategy.
fgenbarchartopinionfibrogencs
https://www.barchart.com/stocks/quotes/FGEN/price-history/historical
FGEN Price History for Fibrogen CS Stock - Barchart.com
The historical data and Price History for Fibrogen Inc CS (FGEN) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download.
price historyfgenfibrogencsstock
https://www.barchart.com/stocks/quotes/FGEN/trading-strategies
FGEN Trading Strategies for Fibrogen CS Stock - Barchart.com
trading strategiesfgenfibrogencsstock
https://www.barchart.com/stocks/quotes/FGEN/balance-sheet
FGEN Balance Sheet for Fibrogen CS Stock - Barchart.com
Balance Sheet for Fibrogen Inc CS (FGEN) with Annual and Quarterly reports.
balance sheetfgenfibrogencsstock
https://www.globenewswire.com/fr/news-release/2021/10/25/2319699/33525/en/FibroGen-Announces-Analyses-from-Roxadustat-Global-Phase-3-Program-at-American-Society-of-Nephrology-Kidney-Week-2021.html
FibroGen Announces Analyses from Roxadustat Global Phase 3
SAN FRANCISCO, Oct. 25, 2021 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced that analyses from the global Phase 3 roxadustat clinical...
fibrogenannouncesanalysesroxadustatglobal